{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:56:15Z","timestamp":1761929775563},"reference-count":34,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,2]]},"abstract":"<jats:p>Artemisinin-based combination therapies (ACTs) are currently used as the first-line therapy for uncomplicated <jats:italic>Plasmodium falciparum<\/jats:italic> malaria. However, the recent emergence and\/or spread of artemisinin resistance in parts of Greater Mekong Subregion (GMS) of southeast Asia requires close monitoring of the therapeutic efficacy of ACTs. This study was conducted from March 2012 to December 2013 in four clinics and seven villages along the China\u2013Myanmar border. A total of 109 patients with uncomplicated falciparum malaria were treated with dihydroartemisinin\u2013piperaquine (DP) and followed up on days 1, 2, 3, 7, 14, 21, 28, and 42 after treatment. A total of 71 patients (22 children and 49 adults) completed the 42-day follow-up. DP remained highly efficacious for treatment of uncomplicated falciparum malaria with an overall 42-day cure rate of 100%. The day 3 parasite-positive rate was 7.04% (5\/71). Within 14 days of treatment, a total of 13 (18.31%) patients had detectable gametocytes and a large proportion of these were persistent from the first three days of treatment. The presence of gametocytes in patients through 14 days after DP treatment suggests that the incorporation of a single dose of primaquine for clearing gametocytemia should be considered for blocking parasite transmission.<\/jats:p>","DOI":"10.4269\/ajtmh.15-0029","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T02:10:23Z","timestamp":1439863823000},"page":"577-583","source":"Crossref","is-referenced-by-count":25,"title":["Clinical Efficacy of Dihydroartemisinin\u2013Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria at the China\u2013Myanmar Border"],"prefix":"10.4269","volume":"93","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofa","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"R1","series-title":"Acta Trop","first-page":"227","article-title":"Malaria in the Greater Mekong Subregion: heterogeneity and complexity","volume":"121","author":"Cui","year":"2012"},{"issue":"(Suppl 1)","key":"R2","series-title":"Southeast Asian J Trop Med Public Health","first-page":"46","article-title":"Malaria situation in the Greater Mekong Subregion","volume":"44","author":"Hewitt","year":"2014"},{"key":"R3","series-title":"Lancet","first-page":"1566","article-title":"Shrinking the malaria map: progress and prospects","volume":"376","author":"Feachem","year":"2010"},{"key":"R4","series-title":"PLoS One","first-page":"e19283","article-title":"Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial","volume":"6","author":"Bethell","year":"2011"},{"key":"R5","series-title":"N Engl J Med","first-page":"455","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009"},{"key":"R6","series-title":"Clin Infect Dis","first-page":"e82","article-title":"Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in southeast Asia","volume":"51","author":"Noedl","year":"2010"},{"key":"R7","series-title":"Lancet Infect Dis","first-page":"851","article-title":"Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study","volume":"12","author":"Amaratunga","year":"2012"},{"key":"R8","series-title":"N Engl J Med","first-page":"2619","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008"},{"year":"2013","series-title":"World Malaria Report 2013","author":"WHO","key":"R9"},{"key":"R10","series-title":"Malar J","first-page":"355","article-title":"In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam","volume":"11","author":"Hien","year":"2012"},{"issue":"(Suppl 1)","key":"R11","series-title":"Southeast Asian J Trop Med Public Health","first-page":"201","article-title":"Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010","volume":"44","author":"Bustos","year":"2013"},{"key":"R12","series-title":"N Engl J Med","first-page":"411","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014"},{"year":"2011","series-title":"Global Plan for Artemisinin Resistance Containment (GPARC)","author":"WHO","key":"R13"},{"key":"R14","series-title":"Lancet","first-page":"1960","article-title":"Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study","volume":"379","author":"Phyo","year":"2012"},{"key":"R15","series-title":"Malar J","first-page":"411","article-title":"Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives","volume":"12","author":"Flegg","year":"2013"},{"key":"R16","series-title":"Malar J","first-page":"125","article-title":"Early parasitological response following artemisinin-containing regimens: a critical review of the literature","volume":"12","author":"Das","year":"2013"},{"key":"R17","series-title":"J Infect Dis","first-page":"570","article-title":"In vivo parasitological measures of artemisinin susceptibility","volume":"201","author":"Stepniewska","year":"2010"},{"key":"R18","series-title":"Chin J Parasitol Parasit Dis","first-page":"372","article-title":"Therapeutic efficacy and safety of compound dihydroartemisinin\/piperaquine for uncomplicated Plasmodium falciparum infection in Laiza city of Myanmar bordering on China","volume":"29","author":"Sun","year":"2011"},{"key":"R19","series-title":"Malar J","first-page":"278","article-title":"Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border","volume":"11","author":"Huang","year":"2012"},{"key":"R20","series-title":"Malar J","first-page":"361","article-title":"Risk factors associated with slide positivity among febrile patients in a conflict zone of north-eastern Myanmar along the China-Myanmar border","volume":"12","author":"Li","year":"2013"},{"key":"R21","series-title":"Science","first-page":"330","article-title":"Qinghaosu (artemisinin): the price of success","volume":"320","author":"White","year":"2008"},{"key":"R22","series-title":"Curr Opin Infect Dis","first-page":"531","article-title":"Artemisinin-based combinations","volume":"18","author":"Ashley","year":"2005"},{"key":"R23","series-title":"Guidelines for the Treatment of Malaria","first-page":"194 pp","author":"WHO","year":"2010"},{"key":"R24","series-title":"Drugs","first-page":"75","article-title":"Piperaquine: a resurgent antimalarial drug","volume":"65","author":"Davis","year":"2005"},{"key":"R25","series-title":"Clin Infect Dis","first-page":"425","article-title":"A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria","volume":"41","author":"Ashley","year":"2005"},{"key":"R26","series-title":"PLoS ONE","first-page":"e2390","article-title":"Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda","volume":"3","author":"Yeka","year":"2008"},{"key":"R27","series-title":"Clin Infect Dis","first-page":"1629","article-title":"Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children","volume":"49","author":"Arinaitwe","year":"2009"},{"key":"R28","series-title":"PLoS Clin Trials","first-page":"e20","article-title":"Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial","volume":"2","author":"Kamya","year":"2007"},{"key":"R29","series-title":"Clin Infect Dis","first-page":"509","article-title":"Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria","volume":"59","author":"Wanzira","year":"2014"},{"key":"R30","series-title":"Development of a Strategy Towards Elimination of Plasmodium falciparum Parasites with Altered Response to Artemisinins","first-page":"52 pp","author":"WHO","year":"2009"},{"key":"R31","series-title":"Nature","first-page":"50","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014"},{"key":"R32","series-title":"Antimicrob Agents Chemother","first-page":"1413","article-title":"Assessment of the pharmacodynamic properties of antimalarial drugs in vivo","volume":"41","author":"White","year":"1997"},{"key":"R33","series-title":"PLoS One","first-page":"e53772","article-title":"Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children","volume":"8","author":"Yeka","year":"2013"},{"key":"R34","series-title":"Malar J","first-page":"168","article-title":"Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007\u20132012","volume":"14","author":"Wang","year":"2015"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/93\/3\/article-p577.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/93\/3\/article-p577.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/93\/3\/article-p577.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:05:23Z","timestamp":1723057523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/93\/3\/article-p577.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":34,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.15-0029","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"type":"print","value":"0002-9637"},{"type":"electronic","value":"1476-1645"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}